Psychedelic-inspired drugs show promise in treating depression without hallucinations.
Researchers studying the effects of LSD and psilocin on mice have found that the drugs' molecular mechanism that cause the psychedelic effects appears to be entirely separate than the way the compounds alleviate depression. This means it may be possible to develop drugs that can help with depression without requiring the patient to trip. However, extensive human tests would be needed to confirm that revamped psychedelics both relieve depression and are not hallucinogenic.